These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 8894176)

  • 1. Effects of cantharidin on force of contraction and phosphatase activity in nonfailing and failing human hearts.
    Linck B; Boknik P; Knapp J; Müller FU; Neumann J; Schmitz W; Vahlensieck U
    Br J Pharmacol; 1996 Oct; 119(3):545-50. PubMed ID: 8894176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism underlying the reduced positive inotropic effects of the phosphodiesterase III inhibitors pimobendan, adibendan and saterinone in failing as compared to nonfailing human cardiac muscle preparations.
    von der Leyen H; Mende U; Meyer W; Neumann J; Nose M; Schmitz W; Scholz H; Starbatty J; Stein B; Wenzlaff H
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Jul; 344(1):90-100. PubMed ID: 1723153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of inotropic interventions on the force-frequency relation in the human heart.
    Bavendiek U; Brixius K; Münch G; Zobel C; Müller-Ehmsen J; Schwinger RH
    Basic Res Cardiol; 1998; 93 Suppl 1():76-85. PubMed ID: 9833134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of isomazole on force of contraction and phosphodiesterase isoenzymes I-IV in nonfailing and failing human hearts.
    Bethke T; Klimkiewicz A; Kohl C; von der Leyen H; Mehl H; Mende U; Meyer W; Neumann J; Schmitz W; Scholz H
    J Cardiovasc Pharmacol; 1991 Sep; 18(3):386-97. PubMed ID: 1720839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positive inotropic effects of the novel Na+-channel modulator BDF 9198 in human nonfailing and failing myocardium.
    Müller-Ehmsen J; Brixius K; Schwinger RH
    J Cardiovasc Pharmacol; 1998 May; 31(5):684-9. PubMed ID: 9593067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. (-)-Adrenaline elicits positive inotropic, lusitropic, and biochemical effects through beta2 -adrenoceptors in human atrial myocardium from nonfailing and failing hearts, consistent with Gs coupling but not with Gi coupling.
    Molenaar P; Savarimuthu SM; Sarsero D; Chen L; Semmler AB; Carle A; Yang I; Bartel S; Vetter D; Beyerdörfer I; Krause EG; Kaumann AJ
    Naunyn Schmiedebergs Arch Pharmacol; 2007 Mar; 375(1):11-28. PubMed ID: 17295024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increase in force of contraction by activation of the Na+/Ca(2+)-exchanger in human myocardium.
    Müller-Ehmsen J; Frank K; Brixius K; Schwinger RH
    Br J Clin Pharmacol; 1997 Apr; 43(4):399-405. PubMed ID: 9146852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Basal and isoprenaline-stimulated cAMP content in failing versus nonfailing human cardiac preparations.
    Danielsen W; v der Leyen H; Meyer W; Neumann J; Schmitz W; Scholz H; Starbatty J; Stein B; Döring V; Kalmár P
    J Cardiovasc Pharmacol; 1989 Jul; 14(1):171-3. PubMed ID: 2475709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of beta(3)-adrenoceptors and altered contractile response to inotropic amines in human failing myocardium.
    Moniotte S; Kobzik L; Feron O; Trochu JN; Gauthier C; Balligand JL
    Circulation; 2001 Mar; 103(12):1649-55. PubMed ID: 11273992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positive and negative inotropic effects of DL-sotalol and D-sotalol in failing and nonfailing human myocardium under physiological experimental conditions.
    Holubarsch C; Schneider R; Pieske B; Ruf T; Hasenfuss G; Fraedrich G; Posival H; Just H
    Circulation; 1995 Nov; 92(10):2904-10. PubMed ID: 7586258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ca++ sensitizers impair cardiac relaxation in failing human myocardium.
    Hajjar RJ; Schmidt U; Helm P; Gwathmey JK
    J Pharmacol Exp Ther; 1997 Jan; 280(1):247-54. PubMed ID: 8996203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of inotropic stimulation on the negative force-frequency relationship in the failing human heart.
    Schwinger RH; Böhm M; Müller-Ehmsen J; Uhlmann R; Schmidt U; Stäblein A; Uberfuhr P; Kreuzer E; Reichart B; Eissner HJ
    Circulation; 1993 Nov; 88(5 Pt 1):2267-76. PubMed ID: 8222121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced alpha 1- and beta 2-adrenoceptor-mediated positive inotropic effects in human end-stage heart failure.
    Steinfath M; Danielsen W; von der Leyen H; Mende U; Meyer W; Neumann J; Nose M; Reich T; Schmitz W; Scholz H
    Br J Pharmacol; 1992 Feb; 105(2):463-9. PubMed ID: 1348446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of forskolin on the force-frequency behavior in nonfailing and end-stage failing human myocardium.
    Pieske B; Trost S; Schütt K; Minami K; Just H; Hasenfuss G
    Basic Res Cardiol; 1998; 93 Suppl 1():66-75. PubMed ID: 9833133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enantioselective inotropic actions of the Na+-channel activators BDF 9148, BDF 9196 and BDF 9167 in human failing and nonfailing myocardium.
    Schwinger RH; Müller-Ehmsen J; Böhm M; Erdmann E
    J Pharmacol Exp Ther; 1996 Mar; 276(3):1180-8. PubMed ID: 8786551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression, activity and functional significance of inducible nitric oxide synthase in the failing human heart.
    Drexler H; Kästner S; Strobel A; Studer R; Brodde OE; Hasenfuss G
    J Am Coll Cardiol; 1998 Oct; 32(4):955-63. PubMed ID: 9768717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered inotropism in the failing human myocardium.
    Bavendiek U; Brixius K; Frank K; Reuter H; Pietsch M; Gross A; Müller-Ehmsen J; Erdmann E; Schwinger RH
    Basic Res Cardiol; 1996; 91 Suppl 2():9-16. PubMed ID: 8957538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subsensitivity of the failing human heart to isoprenaline and milrinone is related to beta-adrenoceptor downregulation.
    Böhm M; Diet F; Feiler G; Kemkes B; Kreuzer E; Weinhold C; Erdmann E
    J Cardiovasc Pharmacol; 1988 Dec; 12(6):726-32. PubMed ID: 2467092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of cAMP-phosphodiesterase inhibition and sensitization of the contractile proteins for calcium to the inotropic effect of pimobendan in the failing human myocardium.
    Böhm M; Morano I; Pieske B; Rüegg JC; Wankerl M; Zimmermann R; Erdmann E
    Circ Res; 1991 Mar; 68(3):689-701. PubMed ID: 1660359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of ketamine on the contractility of failing and nonfailing human heart muscles in vitro.
    Sprung J; Schuetz SM; Stewart RW; Moravec CS
    Anesthesiology; 1998 May; 88(5):1202-10. PubMed ID: 9605679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.